News
Cancer Research UK partners with Aleta Biotherapeutics on blood cancer therapy
Cancer Research UK (CRUK) and biotech company Aleta Biotherapeutics have entered into a collaboration on the early phase clinical development of Aleta’s blood cancer therapy candidate ALETA-001.